ALICIA JOHNSON: Open Payments
NPI 1225593866 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 34 payments from 11 companies in 2025. Trend: 2023 $506 · 2024 $755 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $226 |
| PFIZER INC. | 4 | $146 |
| Daiichi Sankyo Inc. | 5 | $114 |
| Janssen Biotech, Inc. | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| BeOne Medicines USA, Inc. | 2 | $45 |
| Eisai Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Genmab U.S., Inc. | 1 | $19 |
| TerSera Therapeutics LLC | 1 | $16 |
Products named: KEYTRUDA, DATROWAY, KISQALI, RYBREVANT, DARZALEX, BRUKINSA, Lenvima, LYNPARZA.
Industry payments across NC — which companies pay providers there.
